Monoclonal Antibody Therapeutics to Fill Vacuum Left by Ineffective Conventional Therapies
28-Jan-2005 -
Currently, the limited efficacy of conventional therapies, especially in the case of several oncology and autoimmune and inflammatory disorders (AIID),
is creating the need for safe and effective treatment alternatives. While this situation
has promoted demand for monoclonal antibodies (mAbs), ...
antigens
biopharmaceuticals
Crohn's disease
+10